¼¼°èÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå(2024³âÆÇ) : À¯Çüº°, Ä¡·á Á¢±Ù¹ýº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ±¹°¡º° ºÐ¼®, ½ÃÀå ÀλçÀÌÆ® ¹× ¿¹Ãø(2020-2030³â)
Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
»óǰÄÚµå : 1473853
¸®¼­Ä¡»ç : Azoth Analytics
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,450 £Ü 3,476,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 2,950 £Ü 4,186,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå ±Ô¸ð´Â 2020-2023³â¿¡ CAGR·Î 3.62%ÀÇ ¼ºÀåÀ» º¸¿´½À´Ï´Ù.

½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 71¾ï 8,000¸¸ ´Þ·¯À̸ç, 2030³â±îÁö 96¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ƯÈ÷ ºÎÀ¯Ãþ »çÀÌ¿¡¼­ °¡Ã³ºÐ ¼Òµæ ¼öÁØÀÌ »ó½ÂÇϰí Àֱ⠶§¹®¿¡ °í±Þ ¾ÈƼ ¿¡ÀÌ¡ ¼ö¼ú°ú ½ºÅ² Äɾî Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¾Æ½ºÆä¸£±æ·ç½ºÁõ°ú Ä­µð´ÙÁõÀº ¼¼°è¿¡¼­ °¡Àå ÈçÇÑ Áø±Õ °¨¿°Áõ Áß ÇϳªÀ̸ç, À̽ÄÀ» ¹ÞÀº ȯÀÚ, È­Çпä¹ýÀ» ¹Þ°í ÀÖ´Â ¾Ï ȯÀÚ, HIV/AIDS ȯÀÚ µî ¸é¿ª·ÂÀÌ ÀúÇÏµÊ »ç¶÷¿¡°Ô °¨¿°µË´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°Àº ½É°¢ÇÑ Æó °¨¿°, Ç÷·ù °¨¿°, ħ½À¼º °¨¿°À¸·Î ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, ½Å¼ÓÇÏ°Ô Áø´Ü ¹× Ä¡·áÇÏÁö ¾ÊÀ¸¸é »ó´çÇÑ ÀÌȯÀ²°ú »ç¸Á·üÀ» ÃÊ·¡ÇÕ´Ï´Ù.

Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõÀÇ Ä¡·á´Â Ç×Áø±ÕÁ¦°¡ ±âº»ÀÌ µÇ°í, ¾ÆÁ¹°è, ¿¡Å°³ëÄ­µò°è, Æú¸®¿£°è°¡ ÁÖµÈ Ä¡·á ¿É¼ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. Ç¥ÁØ Ä¡·á°¡ À¯È¿ÇÏÁö ¾Ê°Å³ª ¾à¹° ³»¼ºÀÌ ³ªÅ¸³ª´Â °æ¿ì¿¡´Â ÀÌ·¯ÇÑ ¾à¹°À» º´¿ëÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ħ½À¼º Æó ¾Æ½ºÆä¸£±æ·ç½ºÁõÀ̳ª Áø±Õ¼º ½É³»¸·¿°°ú °°Àº ƯÁ¤ ½Ã³ª¸®¿À¿¡¼­´Â º¸Á¶ ¿ä¹ýÀ¸·Î ¼ö¼úÀÌ Çã¿ëµÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀåÀº Áø±Õ °¨¿° Áõ°¡, Áø´Ü ¹æ¹ýÀÇ °³¼±, ÀÇ·á Á¾»çÀÚ¿Í »ç¶÷µéÀÇ ÀÇ½Ä Áõ°¡, Ç×Áø±Õ Ä¡·áÀÇ È®´ë¿¡ ÀÇÇØ ±â¼¼¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÈ­, ¸é¿ª¾ïÁ¦ Ä¡·á, ¿ø³» °¨¿° µîÀÇ ¿äÀεµ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Á¦¾à ±â¾÷°ú ÀÇ·á ±â°üÀ» Æ÷ÇÔÇÑ ÁÖ¿ä ±â¾÷ÀÇ °Ý·ÄÇÑ °æÀïÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº ÀÇ·á Á¦°ø¾÷ü, °Ë»ç½Ç, ȯÀÚÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇØ Áö¼ÓÀûÀ¸·Î ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇÏ¿© »õ·Î¿î Á¦Ç°°ú ¼Ö·ç¼ÇÀ» ¹ßÇ¥Çϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­´Â ¼¼°è Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Áö¿ª ¹× ºÎ¹® ºÐ¼®, ÁÖ¿ä µ¿Çâ°ú ±âȸ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹è°æ

Á¦2Àå ºÐ¼®°¡ Ãßõ

Á¦3Àå ¼¼°èÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå : ½ÇÀû°ú ¿¹Ãø

Á¦4Àå ¼¼°èÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå, Áö¿ªÀÇ ºÐ¼®

Á¦5Àå ¾Æ¸Þ¸®Ä«ÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå : ½ÇÀû°ú ¿¹Ãø

Á¦6Àå À¯·´ÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå : ½ÇÀû°ú ¿¹Ãø

Á¦7Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå : ½ÇÀû°ú ¿¹Ãø

Á¦8Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àü½Å ¾Æ½ºÆä¸£±æ·ç½ºÁõ ¹× Àü½Å Ä­µð´ÙÁõ ½ÃÀå : ½ÇÀû°ú ¿¹Ãø

Á¦9Àå ½ÃÀå ¿ªÇÐ

Á¦10Àå »ê¾÷ »ýÅÂ°è ºÐ¼®

Á¦11Àå °æÀï Æ÷Áö¼Å´×

Á¦12Àå ´ç»ç¿¡ ´ëÇÏ¿© ¸éÃ¥»çÇ×

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Executive Summary

Azoth Analytics has released a research report titled "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)" which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, Aspergillosis), By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention) By End Users (Hospitals, Clinics, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Systemic Aspergillosis and Systemic Candidiasis market showcased growth at a CAGR of 3.62% during 2020-2023.

The market was valued at USD 7.18 Billion in 2023 which is expected to reach USD 9.62 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging Surgical Intervention and skincare products.

Aspergillosis and candidiasis are among the most common fungal infections worldwide, affecting individuals with compromised immune systems, such as transplant recipients, cancer patients

undergoing chemotherapy, and those with HIV/AIDS. These infections can manifest as severe pulmonary, bloodstream, or invasive infections, leading to substantial morbidity and mortality if not promptly diagnosed and treated.

Antifungal drugs continue to serve as the foundation for treating systemic aspergillosis and systemic candidiasis, with azoles, echinocandins, and polyenes representing the primary

treatment options. Combinations of these medications may be utilized in cases where standard therapy proves ineffective or to combat instances of emerging drug resistance. In certain

scenarios, such as invasive pulmonary aspergillosis or fungal endocarditis, surgical procedures may be warranted as adjunctive therapy.

The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences momentum due to rising occurrences of fungal infections, improved diagnostic methods, heightened awareness among healthcare practitioners and individuals, and the expanding array of antifungal treatments. Furthermore, factors such as population aging, immunosuppressive treatments, and hospital- acquired transmissions bolster the market's expansion.

The market is characterized by intense competition among key players, including pharmaceutical companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

Table of Contents

Table of Content

1. Market Background

2. Analyst Recommendations

3. Global Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

4. Global Systemic Aspergillosis and Systemic Candidiasis Market, Region Analysis

5. Americas Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

6. Europe Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

7. Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

8. Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

9. Market Dynamics

10. Industry Ecosystem Analysis

11. Competitive Positioning

12. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â